121 related articles for article (PubMed ID: 24323633)
1. Benefits of acupuncture for diabetic gastroparesis: a comparative preliminary study.
Danielli Miller N; Schiff E; Ben-Arye E; Singer J; Tsadok Perets T; Flaut S; Sahar N; Niv Y; Dickman R
Acupunct Med; 2014 Apr; 32(2):139-45. PubMed ID: 24323633
[TBL] [Abstract][Full Text] [Related]
2. The short-term effects of acupuncture on patients with diabetic gastroparesis: a randomised crossover study.
Li G; Huang C; Zhang X; Xie H; Cheng H; Tang Y; Li Z
Acupunct Med; 2015 Jun; 33(3):204-9. PubMed ID: 25689986
[TBL] [Abstract][Full Text] [Related]
3. Acupuncture for symptomatic relief of gastroparesis in a diabetic haemodialysis patient.
Kim KH; Kim TH; Choi JY; Kim JI; Lee MS; Choi SM
Acupunct Med; 2010 Jun; 28(2):101-3. PubMed ID: 20466737
[TBL] [Abstract][Full Text] [Related]
4. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
[TBL] [Abstract][Full Text] [Related]
5. [Clinical research of acupuncture therapy combined with domperidone in treatment of diabetic gastroparesis of liver stagnation and spleen deficiency].
Chen J; Liang FX; Wu S; Chen ZQ; Chen B; Zhou T; Gu XL; Li CL; Shi YP; Yan P; Tian LL; Xu CC; Chen BL; Chen S
Zhen Ci Yan Jiu; 2023 Jan; 48(1):88-94. PubMed ID: 36734504
[TBL] [Abstract][Full Text] [Related]
6. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
8. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
[TBL] [Abstract][Full Text] [Related]
9. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative gastric emptying time correlates with clinical response to gastric electrical stimulation in the treatment of gastroparesis.
O'Loughlin PM; Gilliam AD; Shaban F; Varma JS
Surgeon; 2013 Jun; 11(3):134-40. PubMed ID: 23206591
[TBL] [Abstract][Full Text] [Related]
11. Development and content validity of a gastroparesis cardinal symptom index daily diary.
Revicki DA; Camilleri M; Kuo B; Norton NJ; Murray L; Palsgrove A; Parkman HP
Aliment Pharmacol Ther; 2009 Sep; 30(6):670-80. PubMed ID: 19558608
[TBL] [Abstract][Full Text] [Related]
12. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
[TBL] [Abstract][Full Text] [Related]
13. [Effects of different acupuncture intensities on the therapeutic effect and the gastric electric activity in the patient of diabetic gastroparesis].
Zeng HW; Nie B; Ge Y; Wang H; Song XJ
Zhongguo Zhen Jiu; 2006 Sep; 26(9):644-6. PubMed ID: 17036484
[TBL] [Abstract][Full Text] [Related]
14. Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis.
Wang L
J Tradit Chin Med; 2004 Sep; 24(3):163-5. PubMed ID: 15510787
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.
Pasricha PJ; Yates KP; Nguyen L; Clarke J; Abell TL; Farrugia G; Hasler WL; Koch KL; Snape WJ; McCallum RW; Sarosiek I; Tonascia J; Miriel LA; Lee L; Hamilton F; Parkman HP
Gastroenterology; 2015 Dec; 149(7):1762-1774.e4. PubMed ID: 26299414
[TBL] [Abstract][Full Text] [Related]
16. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
[TBL] [Abstract][Full Text] [Related]
17. Obesity and symptoms suggestive of gastroparesis in patients with type 2 diabetes and neuropathy.
Boaz M; Kislov J; Dickman R; Wainstein J
J Diabetes Complications; 2011; 25(5):325-8. PubMed ID: 21813291
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus.
Dickman R; Kislov J; Boaz M; Ron Y; Beniashvili Z; Raz I; Baigel I; Niv Y; Wainstein J
J Diabetes Complications; 2013; 27(4):376-9. PubMed ID: 23507560
[TBL] [Abstract][Full Text] [Related]
20. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy.
Cassilly DW; Wang YR; Friedenberg FK; Nelson DB; Maurer AH; Parkman HP
Digestion; 2008; 78(2-3):144-51. PubMed ID: 19033686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
